Extract

Efficacy and safety of BI 1356 compared to placebo in patients with type 2 diabetes who have insufficient glycaemic control despite treatment with a sulfonylurea drug.

Inclusion criteria

• Diabetes Mellitus, Type 2

Country

• Argentina
• Hungary
• India
• Japan
• Poland
• Russian Federation
• United States

Links

• nct
• ictrp